Pediatric Extrapolation in Neuropsychiatric Drug Development: Leveraging Pharmacokinetic and Pharmacodynamic Strategies to Facilitate FDA Approvals.

Nookala AR, Murphy WA, Panse N, Bewernitz M, Bhattaram A, Delvadia P, Pillai VC, Kwatra D, Xu Y, Uppoor R, Mehta M, Sabarinath S, Gottipati G.

Open source

DOI
10.1002/cpt.70412
Published
2026-07-30
Container
Clin Pharmacol Ther
Publisher
Not recorded
Open access
no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1002/cpt.70412,
  title = {Pediatric Extrapolation in Neuropsychiatric Drug Development: Leveraging Pharmacokinetic and Pharmacodynamic Strategies to Facilitate FDA Approvals.},
  author = {Nookala AR and  Murphy WA and  Panse N and  Bewernitz M and  Bhattaram A and  Delvadia P and  Pillai VC and  Kwatra D and  Xu Y and  Uppoor R and  Mehta M and  Sabarinath S and  Gottipati G.},
  year = {2026},
  journal = {Clin Pharmacol Ther},
  doi = {10.1002/cpt.70412},
  url = {https://doi.org/10.1002/cpt.70412}
}

RIS

TY  - JOUR
TI  - Pediatric Extrapolation in Neuropsychiatric Drug Development: Leveraging Pharmacokinetic and Pharmacodynamic Strategies to Facilitate FDA Approvals.
AU  - Nookala AR
AU  -  Murphy WA
AU  -  Panse N
AU  -  Bewernitz M
AU  -  Bhattaram A
AU  -  Delvadia P
AU  -  Pillai VC
AU  -  Kwatra D
AU  -  Xu Y
AU  -  Uppoor R
AU  -  Mehta M
AU  -  Sabarinath S
AU  -  Gottipati G.
PY  - 2026
JO  - Clin Pharmacol Ther
DO  - 10.1002/cpt.70412
UR  - https://doi.org/10.1002/cpt.70412
ER  - 

APA

AR, N., WA, M., N, P., M, B., A, B., P, D., VC, P., D, K., Y, X., R, U., M, M., S, S., & G., G. (2026). Pediatric Extrapolation in Neuropsychiatric Drug Development: Leveraging Pharmacokinetic and Pharmacodynamic Strategies to Facilitate FDA Approvals.. Clin Pharmacol Ther. https://doi.org/10.1002/cpt.70412

Source records